Santhera Pharmaceuticals Holding AG

10/06/2020 | Press release | Distributed by Public on 10/05/2020 23:05

Santhera to Discontinue Phase 3 SIDEROS Study and Development of Puldysa® in Duchenne Muscular Dystrophy (DMD) and Focus on Vamorolone